This site is intended for healthcare professionals only
LoginRegister
Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel DiseaseAbbVie concludes acquisition of ImmunoGen
USV Acquires 79% Stake in Wellbeing Nutrition, Values D2C Startup at Rs 1,583 CrEris buys 51 percent stake in Swiss Parenterals for Rs 637.5 crore
Rajasthan Chemists Warn of Indefinite Strike Over Rs 880 Crore Unpaid Govt DuesNoccarc raises USD 2 million from IAN, others
Natco Pharma gets 7 USFDA observations for Kothur Pharma DivisionUSFDA successfully concludes inspection at Unichem Labs Ghaziabad facility
Lupin and TB Alliance Join Forces to Advance TelacebecLupin unveils Bromfenac Ophthalmic Solution, 0.075% in US
CDSCO Expert Panel Backs Akums Faropenem Dispersible Tablets, Grants CT, BE WaiversAkums Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Drug
Pfizer Awards Rs 60 Lakh Each to 14 Healthtech Startups Under INDovation 2025Pfizer, UT Southwestern collaborate to develop improved RNA Delivery Technologies
Aurobindo Pharma arm Unit IV gets 5 USFDA observationsDr Reddy's Labs gets USFDA VAI classification for Hyderabad RnD centre
CDSCO Panel Flags Ethnic Variability, Seeks More Data from Takeda for Fruquintinib Hard Capsule ApprovalTakeda Eohilia gets USFDA nod for people aged 11 years and older with eosinophilic esophagitis
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentGilead Sciences to acquire CymaBay Therapeutics for USD 4.3 billion
USFDA Approves Bionpharmas Generic HIV Drug EtravirineAurobindo Pharma bags USFDA okay for Duchenne muscular dystrophy drug Deflazacort
CDSCO Panel rejects Synokem proposal for FDC of Mecobalamin, Nortriptyline, PregabalinCDSCO Panel rejects Synokem proposal for FDC of Mecobalamin, Nortriptyline, Pregabalin
X